Davis Polk advised the bookrunners, led by Deutsche Bank Securities Inc., on the offering. Hilton Grand Vacations Borrower Escrow LLC and Hilton Grand Vacations Borrower Escrow...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the initial purchasers on the offering. LGI Homes, Inc. completed the offering of $300 million aggregate principal amount of its 4.000%...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the IPO. Sprinklr, Inc. completed its $254 million initial public offering of 16,625,000 shares of Class A...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. Theravance Biopharma, Inc. executed its $100.5 million public offering of ordinary shares. Theravance Biopharma’s ordinary shares are listed on the Nasdaq...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. Summit Healthcare Acquisition Corp. completed its initial public offering of 200,000,000 units for aggregate proceeds of $200 million. Each...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Clarivate Science Holdings Corporation on the offering. Clarivate Science Holdings Corporation, an indirect wholly-owned subsidiary of Clarivate Plc, executed a Rule 144A / Regulation S offering of $1 billion...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the underwriters on the offering, and Maples advised Missfresh Limited on the deal. Missfresh Limited completed its initial public offering of...
You must be a Standard 1 Year member to access this content.
Milbank advised the underwriters on the deal, while Davis Polk advised NatWest Group. NatWest Group plc’s (formerly The Royal Bank of Scotland Group plc) announced its...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Century Therapeutics, Inc. executed the $242.7 million initial public offering of 12,132,500 shares of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the IPO. Cyteir Therapeutics, Inc. executed the $133.2 million initial public offering of 7,400,000 shares of common...
You must be a Standard 1 Year member to access this content.
Cravath represented Convey Holding Parent, while Davis Polk advised the representatives of the several underwriters in the offering. Convey Holding Parent, Inc. (“Convey Health”) executed the $186.7...
You must be a Standard 1 Year member to access this content.
